Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
Crossref DOI link: https://doi.org/10.1186/s12933-016-0473-7
Published Online: 2016-11-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kusaka, Hiroaki
Koibuchi, Nobutaka
Hasegawa, Yu
Ogawa, Hisao
Kim-Mitsuyama, Shokei
Funding for this research was provided by:
Boehringer Ingelheim
